A detailed history of Janus Henderson Group PLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 5,177 shares of ANIP stock, worth $308,859. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,177
Previous 5,261 1.6%
Holding current value
$308,859
Previous $363,000 9.37%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$58.53 - $68.82 $4,916 - $5,780
-84 Reduced 1.6%
5,177 $329,000
Q1 2024

May 15, 2024

BUY
$54.2 - $69.69 $162 - $209
3 Added 0.06%
5,261 $363,000
Q4 2023

Feb 14, 2024

SELL
$48.72 - $65.43 $535 - $719
-11 Reduced 0.21%
5,258 $289,000
Q3 2023

Nov 14, 2023

BUY
$50.28 - $64.61 $754 - $969
15 Added 0.29%
5,269 $305,000
Q2 2023

Aug 14, 2023

SELL
$37.29 - $53.83 $298 - $430
-8 Reduced 0.15%
5,254 $282,000
Q1 2023

May 15, 2023

BUY
$37.61 - $45.72 $197,903 - $240,578
5,262 New
5,262 $209,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.04B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.